Evaluation of Influenza A/H3N2 Vaccine in Patients With Rheumatologic Diseases

NCT03540823 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus
Sjogren's Syndrome

Interventions

BIOLOGICAL: Inactivated and fragmented influenza vaccine (A / Michigan / 45/2015 (H1N1) pdm09-like virus, A / Singapore / INFIMH-16-0019 / 2016 (H3N2) -like virus; B / Phuket / 3073/2013-like virus)

Sponsor

University of Sao Paulo General Hospital